(Q42537259)

1 November 2017

title

Potent cyclic urea HIV protease inhibitors with 3-aminoindazole P2/P2' groups (English)

1 reference

1 November 2017

Rodgers JD

1

1 reference

1 November 2017

Johnson BL

2

1 reference

1 November 2017

Wang H

3

1 reference

1 November 2017

Erickson-Viitanen S

4

1 reference

1 November 2017

Klabe RM

5

1 reference

1 November 2017

Bacheler L

6

1 reference

1 November 2017

Cordova BC

7

1 reference

1 November 2017

Chang CH

8

1 reference

1 November 2017

language of work or name

English

0 references

publication date

1 April 1998

1 reference

Bioorganic & Medicinal Chemistry Letters

1 November 2017

published in

1 reference

1 November 2017

volume

8

1 reference

1 November 2017

issue

7

1 reference

1 November 2017

page(s)

715-720

1 reference

Toward improved anti-HIV chemotherapy: therapeutic strategies for intervention with HIV infections

1 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2898%2900118-8

7 January 2021

Targeting HIV-1 protease: a test of drug-design methodologies

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2898%2900118-8

7 January 2021

Structure-based inhibitors of HIV-1 protease

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2898%2900118-8

7 January 2021

Recent advances in the design of HIV proteinase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2898%2900118-8

7 January 2021

HIV protease: a novel chemotherapeutic target for AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2898%2900118-8

7 January 2021

A short-term study of the safety, pharmacokinetics, and efficacy of ritonavir, an inhibitor of HIV-1 protease. European-Australian Collaborative Ritonavir Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2898%2900118-8

7 January 2021

A preliminary study of ritonavir, an inhibitor of HIV-1 protease, to treat HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2898%2900118-8

7 January 2021

Safety and activity of saquinavir in HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2898%2900118-8

7 January 2021

Stereoselective Synthesis of HIV-1 Protease Inhibitor, DMP 323

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2898%2900118-8

7 January 2021

Potency and selectivity of inhibition of human immunodeficiency virus protease by a small nonpeptide cyclic urea, DMP 323

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2898%2900118-8

7 January 2021

Cyclic urea amides: HIV-1 protease inhibitors with low nanomolar potency against both wild type and protease inhibitor resistant mutants of HIV

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2898%2900118-8

7 January 2021

10.1016/S0960-894X(98)00118-8

Identifiers

DOI

1 reference

1 November 2017

1 reference